CIK 0001237831
- Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043744954
- Phone
- +1 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,794,049
- in 3 filings, $425K under 10b5-1 plans
Net −$5,794,049. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-26 | TOBIN JAMES R Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-01-26 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-01-26 | Lemaitre Dan Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-01-26 | Douglas Robert Andrew Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-01-26 | Davidar David D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-01-26 | Huller Kelly SVP, GC, Corporate Secretary | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +30,000 | 30,000 | ||
| 2023-01-26 | Pfeil Keith W SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2023-01-26 | Paul David C Executive Chairman | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +75,000 | 75,000 | ||
| 2023-01-26 | Scavilla Daniel T President, CEO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +100,000 | 100,000 | ||
| 2022-12-01 | Huller Kelly SVP, GC, Corporate Secretary | Exercise or conversion | +7,500 | $12.59 | $94K | 7,500 |
| 2022-12-01 | Huller Kelly SVP, GC, Corporate Secretary | Sale | −7,500 | $75.00 | $563K | 0 |
| 2022-12-01 | Huller Kelly SVP, GC, Corporate Secretary | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −7,500 | 0 | ||
| 2022-08-25 | Lemaitre Dan Director | Other disposition · Stock Option (Right to Buy Class A Common Stock) | −2,250 | 5,250 | ||
| 2022-08-25 | Lemaitre Dan Director | Other disposition · Stock Option (Right to Buy Class A Common Stock) | −3,000 | 7,000 | ||
| 2022-08-25 | Lemaitre Dan Director | Other disposition · Stock Option (Right to Buy Class A Common Stock) | −4,500 | 10,500 | ||
| 2022-08-25 | Lemaitre Dan Director | Other disposition · Stock Option (Right to Buy Class A Common Stock) | −6,000 | 14,000 | ||
| 2022-08-25 | Lemaitre Dan Director | Other disposition · Stock Option (Right to Buy Class A Common Stock) | −7,500 | 17,500 | ||
| 2022-08-25 | Lemaitre Dan Director | Other disposition · Stock Option (Right to Buy Class A Common Stock) | −7,500 | 17,500 | ||
| 2022-08-25 | Lemaitre Dan Director | Other disposition · Stock Option (Right to Buy Class A Common Stock) | −7,500 | 17,500 | ||
| 2022-08-25 | Lemaitre Dan Director | Other disposition · Stock Option (Right to Buy Class A Common Stock) | −7,500 | 17,500 |
Page 11 of 25 · 498 trades